# Decreasing Depression and Anxiety and Their Effect on QoL of ESRD Patients (End-Stage Renal Disease)

> **NCT03330938** · NA · UNKNOWN · sponsor: **Hospital Civil de Guadalajara** · enrollment: 50 (estimated)

## Conditions studied

- End-Stage Renal Disease

## Interventions

- **BEHAVIORAL:** CBI and Resilience
- **BEHAVIORAL:** Cognitive-behavioral Intervention

## Key facts

- **NCT ID:** NCT03330938
- **Lead sponsor:** Hospital Civil de Guadalajara
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-01
- **Primary completion:** 2018-10-23
- **Final completion:** 2018-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03330938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03330938, "Decreasing Depression and Anxiety and Their Effect on QoL of ESRD Patients (End-Stage Renal Disease)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03330938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*